Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3507)
All Articles published online
|
Aug 15, 1998 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu P, Liu C, Xu LM, Hu YY, Xue HM, Liu CH, Zhang ZQ. Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. World J Gastroenterol 1998; 4(4): 348-353 [PMID: 11819318 DOI: 10.3748/wjg.v4.i4.348] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v4/i4/348.htm |
| Number | Citing Articles |
| 1 |
Li Yao, Zhen-Min Yao, Tao Yu. Influence of BOL on hyaluronic acid, laminin and hyperplasia in hepatofibrotic rats. World Journal of Gastroenterology 2001; 7(6): 872-875 doi: 10.3748/wjg.v7.i6.872
|
| 2 |
Xue-Qing Hu, Ya-Nan Song, Rong Wu, Fei-Fei Cai, Yongyu Zhang, Jing-Hua Peng, Yi-Yang Hu, Shi-Bing Su. Metabolic mechanisms of Fuzheng-Huayu formula against liver fibrosis in rats. Journal of Ethnopharmacology 2019; 238: 111888 doi: 10.1016/j.jep.2019.111888
|
| 3 |
K.F. Cheung, D.W. Ye, Z.F. Yang, L. Lu, C.H. Liu, X.L. Wang, R.T.P. Poon, Y. Tong, P. Liu, Y.C. Chen, George K.K. Lau. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. Journal of Ethnopharmacology 2009; 124(1): 142 doi: 10.1016/j.jep.2009.03.005
|
| 4 |
Wang-Xian Tang, Zi-Li Dan, Hong-Mei Yan, Cui-Huan Wu, Guo Zhang, Mei Liu, Qin Li, Shao-Bai Li. Experimental study of effect of Ganyanping on fibrosis in rat livers. World Journal of Gastroenterology 2003; 9(6): 1292-1295 doi: 10.3748/wjg.v9.i6.1292
|
| 5 |
Ping Liu. Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B. Journal of Chinese Integrative Medicine 2003; 1(2): 89 doi: 10.3736/jcim20030204
|
| 6 |
Yong-Hong Xiao, Dian-Wu Liu, Qing Li. Effects of drug serum of anti-fibrosis I herbal compound on calcium in hepatic stellate cell and its molecular mechanism. World Journal of Gastroenterology 2005; 11(10): 1515-1520 doi: 10.3748/wjg.v11.i10.1515
|
| 7 |
Ya-nan Song, Jian Chen, Fei-fei Cai, Yi-yu Lu, Qi-long Chen, Yong-yu Zhang, Ping Liu, Shi-bing Su. A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes. Acta Pharmacologica Sinica 2018; 39(6): 942 doi: 10.1038/aps.2017.101
|
| 8 |
Naglaa M El-Lakkany, Walaa El-Maadawy, Afaf Ain-Shoka, Afkar Badawy, Olfat Hammam, Fatma Ebeid. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni. Clinical and Experimental Pharmacology and Physiology 2011; 38(10): 695 doi: 10.1111/j.1440-1681.2011.05575.x
|
| 9 |
Fenghua Li. Effects of Cordyceps sinensis on dimethylnitrosamine-induced liver fibrosis in rats. Journal of Chinese Integrative Medicine 2006; : 514 doi: 10.3736/jcim20060515
|
| 10 |
Hong Cheng, Hui-Zhong Zhang, Wan-An Shen, Yan-Fang Liu, Fu-Cheng Ma. Expression of RNase H of human hepatitis B virus polymerase in <italic>Escherichia coli</italic>. World Journal of Gastroenterology 2003; 9(3): 513-515 doi: 10.3748/wjg.v9.i3.513
|
| 11 |
Xi-Xian Yao, You-Wei Tang, Dong-Mei Yao, He-Ming Xiu. Effects of Yigan Decoction on proliferation and apoptosis of hepatic stellate cells. World Journal of Gastroenterology 2002; 8(3): 511-514 doi: 10.3748/wjg.v8.i3.511
|
| 12 |
Yan-Yan Tao, Qing-Lan Wang, Li Shen, Wen-Wei Fu, Cheng-Hai Liu. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathwayin vivoandin vitro. Experimental Biology and Medicine 2013; 238(11): 1284 doi: 10.1177/1535370213498979
|
| 13 |
Qun Zhang, Yu-xin Li, Yao Liu, Yi-xin Hou, Bing-bing Zhu, Yun-yi Huang, Ke Shi, Xian-bo Wang. Effects of Adjuvant Chinese Patent Medicine Therapy on Prevention of Variceal Rebleeding: A Retrospective Cohort Study. Chinese Journal of Integrative Medicine 2021; 27(8): 589 doi: 10.1007/s11655-020-3272-7
|
| 14 |
Muriel Huss, Tanja Elger, Johanna Loibl, Arne Kandulski, Benedicta Binder, Petra Stoeckert, Patricia Mester, Martina Müller, Christa Buechler, Hauke Christian Tews. Urinary Hydroxyproline as an Inflammation-Independent Biomarker of Inflammatory Bowel Disease. Gastroenterology Insights 2024; 15(2): 486 doi: 10.3390/gastroent15020035
|
| 15 |
Sami A. Gabr, Ahmad H. Alghadir, Yousery E. Sherif, Ayman A. Ghfar. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016; : 1 doi: 10.1007/978-94-007-7742-2_26-1
|
| 16 |
Qing-Qi Chang, Yi-Feng Pan, Jia-Yi Yang, Rong-Sheng Li, Chun-Lu Yuan, Ya-Fang Liao, Dan-Dan Zhang, Cheng-Hai Liu, Xiang Liu. Antiliver Fibrosis Formula of Fuzheng Huayu Alleviates Inflammatory Response. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/5752803
|
| 17 |
QL Wang. Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/Smads signaling pathway. Journal of Chinese Integrative Medicine 2012; 10(5): 561 doi: 10.3736/jcim20120512
|
| 18 |
Ding-Zhu Shen. A target role for mast cell in the prevention and therapy of hepatic fibrosis. Medical Hypotheses 2008; 70(4): 760 doi: 10.1016/j.mehy.2007.07.042
|
| 19 |
Xiao-Ling Wu, Wei-Zheng Zeng, Pi-Long Wang, Chun-Tao Lei, Ming-De Jiang, Xiao-Bin Chen, Yong Zhang, Hui Xu, Zhao Wang. Effect of compound rhodiola sachalinensis A Bor on CCl<sub>4</sub>-induced liver fibrosis in rats and its probable molecular mechanisms. World Journal of Gastroenterology 2003; 9(7): 1559-1562 doi: 10.3748/wjg.v9.i7.1559
|
| 20 |
Dan-Ying Cheng, Zhi-Min Zhao, Gang Wan, Huan-Wei Zheng, Jia-Quan Huang, Cheng-Hai Liu, Hui-Chun Xing. Impact of Fuzheng Huayu tablet on antiviral effect of entecavir in patients with hepatitis B cirrhosis. Hepatobiliary & Pancreatic Diseases International 2022; 21(5): 479 doi: 10.1016/j.hbpd.2022.03.007
|
| 21 |
Sami A. Gabr, Ahmad H. Alghadir, Yousery E. Sherif, Ayman A. Ghfar. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 471 doi: 10.1007/978-94-007-7675-3_26
|
| 22 |
Rong Wu, Shu Dong, Fei-Fei Cai, Xiao-Le Chen, Meng-Die Yang, Ping Liu, Shi-Bing Su. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis. Molecules 2019; 24(2): 338 doi: 10.3390/molecules24020338
|
| 23 |
Shu Dong, Qi-Long Chen, Shi-Bing Su. Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/125659
|
| 24 |
Yan-yan Tao, Xiu-chuan Yan, Tao Zhou, Li Shen, Zu-long Liu, Cheng-hai Liu. Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis. BMC Complementary and Alternative Medicine 2014; 14(1) doi: 10.1186/1472-6882-14-449
|
| 25 |
Hong-lian Gui, Chang-qing Zhao, Yan Wang, Hong-tu Gu, Wei-jing Wang, Wei Cai, Qing Guo, Shi-san Bao, Lie-ming Xu, Qing Xie. Histological Outcome of Fuzheng Huayu plus Entecavir Combination Therapy in Chronic Hepatitis B Patients with Significant Liver Fibrosis. Journal of Clinical and Translational Hepatology 2020; 8(3): 1 doi: 10.14218/JCTH.2020.00004
|